63 results
8-K
EX-10.1
FENC
Fennec Pharmaceuticals Inc
21 Mar 24
Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand
4:02pm
Purchase Quantities set out above shall be deemed amended accordingly.
Sales Targets Discussion. The JSC’s October meeting each year (as referred … experienced and anticipated, the Parties shall in good faith discuss whether or not any of the sales targets in the Performance Plan should be amended
8-K
EX-1.1
pvvl6e
30 Oct 20
Entry into a Material Definitive Agreement
4:40pm
424B3
mcpya
4 Apr 13
Prospectus supplement
12:00am
POS AM
ctlph3
1 Apr 13
Prospectus update (post-effective amendment)
12:00am
424B3
usfe9xepo
14 Feb 11
Prospectus supplement
12:00am
S-1/A
j4tflip0oqdyj9y4d
9 Feb 11
IPO registration (amended)
12:00am